Shanghai Rongtai Health Tech Working Capital to Net Assets Ratio
Shanghai Rongtai Health Tech working capital to net assets ratio. Shanghai Rongtai Health Tech (603579) has a Working Capital to Net Assets ratio of 46.3% as of June 2026. Working capital of CN¥1.29 Billion (current assets of CN¥2.33 Billion minus current liabilities of CN¥1.04 Billion) is measured against net assets of CN¥2.79 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Shanghai Rongtai Health Tech tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shanghai Rongtai Health Tech (2011–2025)
Working capital to net assets ratio of Shanghai Rongtai Health Tech from 2011 to 2025. This chart shows how Shanghai Rongtai Health Tech's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 46.3%, reflecting working capital of CN¥1.29 Billion against net assets of CN¥2.79 Billion CNY. See Shanghai Rongtai Health Tech defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Shanghai Rongtai Health Tech Working Capital to Net Assets Ratio by Year (2011–2025)
Shanghai Rongtai Health Tech working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Rongtai Health Tech from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 603579 asset base.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 52.7% | CN¥1.47 Billion | CN¥2.79 Billion | CN¥2.17 Billion | CN¥704.52 Million | ▼ -6.5 pp |
| 2024 | 59.2% | CN¥1.19 Billion | CN¥2.02 Billion | CN¥2.18 Billion | CN¥985.22 Million | ▼ -20.0 pp |
| 2023 | 79.1% | CN¥1.56 Billion | CN¥1.97 Billion | CN¥2.23 Billion | CN¥666.60 Million | ▲ +5.3 pp |
| 2022 | 73.8% | CN¥1.38 Billion | CN¥1.87 Billion | CN¥2.27 Billion | CN¥890.15 Million | ▲ +8.3 pp |
| 2021 | 65.5% | CN¥1.17 Billion | CN¥1.78 Billion | CN¥2.04 Billion | CN¥871.72 Million | ▼ -1.9 pp |
| 2020 | 67.4% | CN¥1.11 Billion | CN¥1.65 Billion | CN¥1.82 Billion | CN¥704.57 Million | ▲ +8.2 pp |
| 2019 | 59.2% | CN¥966.25 Million | CN¥1.63 Billion | CN¥1.73 Billion | CN¥768.07 Million | ▼ -6.6 pp |
| 2018 | 65.8% | CN¥986.14 Million | CN¥1.50 Billion | CN¥1.60 Billion | CN¥610.21 Million | ▲ +1.9 pp |
| 2017 | 63.9% | CN¥884.15 Million | CN¥1.38 Billion | CN¥1.66 Billion | CN¥777.21 Million | ▲ +15.3 pp |
| 2016 | 48.6% | CN¥222.25 Million | CN¥457.14 Million | CN¥793.41 Million | CN¥571.16 Million | ▲ +5.9 pp |
| 2015 | 42.7% | CN¥133.55 Million | CN¥312.77 Million | CN¥468.40 Million | CN¥334.85 Million | ▲ +12.8 pp |
| 2014 | 29.9% | CN¥58.45 Million | CN¥195.25 Million | CN¥291.92 Million | CN¥233.47 Million | ▼ -7.3 pp |
| 2013 | 37.2% | CN¥48.55 Million | CN¥130.52 Million | CN¥208.06 Million | CN¥159.51 Million | ▼ -17.4 pp |
| 2012 | 54.6% | CN¥77.50 Million | CN¥141.94 Million | CN¥165.06 Million | CN¥87.57 Million | ▼ -11.7 pp |
| 2011 | 66.3% | CN¥88.33 Million | CN¥133.29 Million | CN¥170.13 Million | CN¥81.80 Million | — |